Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥12,534 | CN¥11,866 | CN¥10,857 | CN¥10,077 |
| - Cash | CN¥1,045 | CN¥743 | CN¥697 | CN¥756 |
| + Debt | CN¥1,283 | CN¥766 | CN¥727 | CN¥785 |
| Enterprise Value | CN¥12,771 | CN¥11,889 | CN¥10,887 | CN¥10,105 |
| Revenue | CN¥659 | CN¥697 | CN¥687 | CN¥707 |
| % Growth | -5.4% | 1.4% | -2.8% | – |
| Gross Profit | CN¥383 | CN¥331 | CN¥311 | CN¥363 |
| % Margin | 58% | 47.4% | 45.3% | 51.3% |
| EBITDA | CN¥155 | CN¥153 | CN¥91 | CN¥47 |
| % Margin | 23.6% | 21.9% | 13.2% | 6.6% |
| Net Income | CN¥60 | CN¥64 | CN¥25 | CN¥17 |
| % Margin | 9.2% | 9.2% | 3.6% | 2.4% |
| EPS Diluted | 0.073 | 0.078 | 0.03 | 0.021 |
| % Growth | -5.4% | 158.3% | 45.6% | – |
| Operating Cash Flow | CN¥75 | CN¥154 | CN¥114 | CN¥102 |
| Capital Expenditures | -CN¥40 | -CN¥89 | -CN¥74 | -CN¥83 |
| Free Cash Flow | CN¥35 | CN¥65 | CN¥40 | CN¥19 |